PROTHENA CORPORATION PUBLIC LIMITED COMPANY Increase (Decrease) in Deferred Revenue
PROTHENA CORPORATION PUBLIC LIMITED COMPANY (PRTA) reported Increase (Decrease) in Deferred Revenue of -$2.04 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredRevenue · last filed 2026-08-06
- PROTHENA CORPORATION PUBLIC LIMITED COMPANY increase (decrease) in deferred revenue for the quarter ending 2026-06-30 was -$1.01M.
- PROTHENA CORPORATION PUBLIC LIMITED COMPANY increase (decrease) in deferred revenue for the quarter ending 2026-03-31 was -$1.03M.
- PROTHENA CORPORATION PUBLIC LIMITED COMPANY increase (decrease) in deferred revenue for the quarter ending 2025-12-31 was -$21.00K.
- PROTHENA CORPORATION PUBLIC LIMITED COMPANY increase (decrease) in deferred revenue for the quarter ending 2025-09-30 was -$2.42M.
- PROTHENA CORPORATION PUBLIC LIMITED COMPANY increase (decrease) in deferred revenue for fiscal 2025 was -$9.63M.
- PROTHENA CORPORATION PUBLIC LIMITED COMPANY increase (decrease) in deferred revenue for fiscal 2024 was -$55.11M.
- PROTHENA CORPORATION PUBLIC LIMITED COMPANY increase (decrease) in deferred revenue for fiscal 2023 was -$29.33M.
- PROTHENA CORPORATION PUBLIC LIMITED COMPANY increase (decrease) in deferred revenue for fiscal 2022 was -$13.86M, a 4081.32% decline from fiscal 2021.
| Period end | Increase (Decrease) in Deferred Revenue 3 month | Increase (Decrease) in Deferred Revenue 6 month | Increase (Decrease) in Deferred Revenue 9 month | Increase (Decrease) in Deferred Revenue 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$1.01M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$2.04M 10-Q · filed 2026-08-06 | -$2.06M derived: sum of 3 quarters · filed 2026-08-06 | -$4.48M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | -$1.03M 10-Q · filed 2026-05-07 | -$1.05M derived: sum of 2 quarters · filed 2026-05-07 | -$3.47M derived: sum of 3 quarters · filed 2026-05-07 | -$7.89M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | -$21.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | -$2.44M derived: sum of 2 quarters · filed 2026-02-27 | -$6.86M derived: sum of 3 quarters · filed 2026-08-06 | -$9.63M 10-K · filed 2026-02-27 |
| 2025-09-30 | -$2.42M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$6.83M derived: sum of 2 quarters · filed 2026-08-06 | -$9.61M 10-Q · filed 2025-11-06 | -$11.74M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | -$4.42M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$7.20M 10-Q · filed 2026-08-06 | -$9.32M derived: sum of 3 quarters · filed 2026-08-06 | -$10.29M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | -$2.78M 10-Q · filed 2026-05-07 | -$4.90M derived: sum of 2 quarters · filed 2026-05-07 | -$5.87M derived: sum of 3 quarters · filed 2026-05-07 | -$57.88M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | -$2.12M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | -$3.09M derived: sum of 2 quarters · filed 2026-02-27 | -$55.11M derived: sum of 3 quarters · filed 2026-02-27 | -$55.11M 10-K · filed 2026-02-27 |
| 2024-09-30 | -$970.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$52.98M derived: sum of 2 quarters · filed 2025-11-06 | -$52.98M 10-Q · filed 2025-11-06 | -$53.30M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-06-30 | -$52.01M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-04 | -$52.01M 10-Q · filed 2025-08-04 | -$52.33M derived: sum of 3 quarters · filed 2026-02-27 | -$77.14M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-03-31 | $0.00 10-Q · filed 2025-05-08 | -$316.00K derived: sum of 2 quarters · filed 2026-02-27 | -$25.12M derived: sum of 3 quarters · filed 2026-02-27 | -$27.21M derived: sum of 4 quarters · filed 2026-02-27 |
| 2023-12-31 | -$316.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | -$25.12M derived: sum of 2 quarters · filed 2026-02-27 | -$27.21M derived: sum of 3 quarters · filed 2026-02-27 | -$29.33M 10-K · filed 2026-02-27 |
| 2023-09-30 | -$24.81M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$26.89M derived: sum of 2 quarters · filed 2024-11-12 | -$29.01M 10-Q · filed 2024-11-12 | -$38.94M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | -$2.09M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | -$4.21M 10-Q · filed 2024-08-08 | -$14.13M derived: sum of 3 quarters · filed 2025-02-27 | -$15.65M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | -$2.12M 10-Q · filed 2024-05-08 | -$12.04M derived: sum of 2 quarters · filed 2025-02-27 | -$13.56M derived: sum of 3 quarters · filed 2025-02-27 | -$14.87M derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | -$9.92M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | -$11.44M derived: sum of 2 quarters · filed 2025-02-27 | -$12.75M derived: sum of 3 quarters · filed 2025-02-27 | -$13.86M 10-K · filed 2025-02-27 |
| 2022-09-30 | -$1.52M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | -$2.83M derived: sum of 2 quarters · filed 2023-11-02 | -$3.93M 10-Q · filed 2023-11-02 | -$5.11M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-06-30 | -$1.31M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | -$2.42M 10-Q · filed 2023-08-03 | -$3.59M derived: sum of 3 quarters · filed 2024-02-22 | -$2.07M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-03-31 | -$1.10M 10-Q · filed 2023-05-04 | -$2.28M derived: sum of 2 quarters · filed 2024-02-22 | -$756.00K derived: sum of 3 quarters · filed 2024-02-22 | -$756.00K derived: sum of 4 quarters · filed 2024-02-22 |
| 2021-12-31 | -$1.17M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $348.00K derived: sum of 2 quarters · filed 2024-02-22 | $348.00K derived: sum of 3 quarters · filed 2024-02-22 | $348.00K 10-K · filed 2024-02-22 |
| 2021-09-30 | $1.52M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $1.52M derived: sum of 2 quarters · filed 2022-11-03 | $1.52M 10-Q · filed 2022-11-03 | $1.52M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $0.00 10-Q · filed 2022-08-08 | $0.00 derived: sum of 3 quarters · filed 2023-02-28 | |
| 2021-03-31 | $0.00 10-Q · filed 2022-05-05 | $0.00 derived: sum of 2 quarters · filed 2023-02-28 | ||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $0.00 10-K · filed 2023-02-28 | ||
| 2020-09-30 | $0.00 10-Q · filed 2021-11-04 | |||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | $0.00 derived: sum of 2 quarters · filed 2022-02-25 | $0.00 derived: sum of 3 quarters · filed 2022-02-25 | $0.00 10-K · filed 2022-02-25 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | $0.00 derived: sum of 2 quarters · filed 2019-11-05 | $0.00 10-Q · filed 2019-11-05 | $0.00 derived: sum of 4 quarters · filed 2021-02-26 |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $0.00 10-Q · filed 2019-08-06 | $0.00 derived: sum of 3 quarters · filed 2021-02-26 | $0.00 derived: sum of 4 quarters · filed 2021-02-26 |
| 2019-03-31 | $0.00 10-Q · filed 2019-05-07 | $0.00 derived: sum of 2 quarters · filed 2021-02-26 | $0.00 derived: sum of 3 quarters · filed 2021-02-26 | $0.00 derived: sum of 4 quarters · filed 2021-02-26 |
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | $0.00 derived: sum of 2 quarters · filed 2021-02-26 | $0.00 derived: sum of 3 quarters · filed 2021-02-26 | $110.24M 10-K · filed 2021-02-26 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | $0.00 derived: sum of 2 quarters · filed 2019-11-05 | $110.24M 10-Q · filed 2019-11-05 | $110.24M derived: sum of 4 quarters · filed 2020-03-03 |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $110.24M 10-Q · filed 2019-08-06 | $110.24M derived: sum of 3 quarters · filed 2020-03-03 | $110.24M derived: sum of 4 quarters · filed 2020-03-03 |
| 2018-03-31 | $110.24M 10-Q · filed 2019-05-07 | $110.24M derived: sum of 2 quarters · filed 2020-03-03 | $110.24M derived: sum of 3 quarters · filed 2020-03-03 | $110.24M derived: sum of 4 quarters · filed 2020-03-03 |
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-03 | $0.00 derived: sum of 2 quarters · filed 2020-03-03 | $0.00 derived: sum of 3 quarters · filed 2020-03-03 | $0.00 10-K · filed 2020-03-03 |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | $0.00 derived: sum of 2 quarters · filed 2018-11-06 | $0.00 10-Q · filed 2018-11-06 | |
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | $0.00 10-Q · filed 2018-08-07 | ||
| 2017-03-31 | $0.00 10-Q · filed 2018-05-09 | |||
| 2016-12-31 | $0.00 10-K · filed 2019-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |